Enrichment with apolipoprotein E characterizes postprandial TG-rich lipoproteins in patients with non-insulin-dependent diabetes mellitus and coronary artery disease: a preliminary report

Atherosclerosis. 1994 Jan;105(1):25-34. doi: 10.1016/0021-9150(94)90004-3.

Abstract

An oral fat-load test was carried out in patients with non-insulin-dependent diabetes mellitus (NIDDM) and angiographically verified coronary artery disease (CAD; group 1, n = 6); in patients with CAD but no diabetes (group 2, n = 6); in patients with NIDDM but no CAD (group 3, n = 4); and in healthy control subjects (group 4, n = 4). Concentrations of apolipoprotein (apo) E, apo C-II, triglyceride (TG), retinyl palmitate, and cholesterol were measured in fasting plasma and in plasma obtained after 2, 4, 6, 9, and 24 h after a meal containing 78 g of fat and 345,000 IU of vitamin A. The same measurements were carried out in the lipoprotein fractions with Svedberg flotation rates Sf 400-1100, 60-400, 20-60 and 12-20, obtained by density gradient ultracentrifugation. The postprandial apo E concentrations were highest in group 1 (NIDDM and CAD) in plasma and in the TG-rich lipoprotein fractions, with significant differences in comparison with the healthy subjects. As shown by apo E to TG ratios, the postprandial lipoproteins were enriched with apo E in the patients with NIDDM and CAD. The largest excesses of apo E in group 1 patients were observed in the atherogenic Sf 12-60 lipoproteins. Across the entire study population, there was a significant inverse correlation between the postprandial apo E responses and the postheparin lipoprotein lipase activity. The results suggest that enrichment of the remnant lipoproteins with apo E may have a role in the increased risk of CAD among patients with NIDDM.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apolipoprotein C-II
  • Apolipoproteins C / metabolism
  • Apolipoproteins E / metabolism*
  • Chylomicrons / blood
  • Coronary Disease / blood*
  • Coronary Disease / complications
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / complications
  • Eating
  • Female
  • Humans
  • Lipase / blood
  • Lipoproteins / blood*
  • Lipoproteins, VLDL / blood
  • Male
  • Middle Aged
  • Triglycerides / blood*
  • Ultracentrifugation

Substances

  • Apolipoprotein C-II
  • Apolipoproteins C
  • Apolipoproteins E
  • Chylomicrons
  • Lipoproteins
  • Lipoproteins, VLDL
  • Triglycerides
  • very low density lipoprotein triglyceride
  • Lipase